Torrent Pharmaceuticals Ltd TORNTPHARM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 2,572.40
- Day Range
- INR 2,522.00–2,625.00
- 52-Week Range
- INR 1,523.05–2,744.00
- Bid/Ask
- INR 2,593.05 / INR 2,600.60
- Market Cap
- INR 880.16 Bil
- Volume/Avg
- 370,338 / 280,209
Key Statistics
- Price/Earnings (Normalized)
- 60.84
- Price/Sales
- 8.53
- Dividend Yield (Trailing)
- 1.15%
- Dividend Yield (Forward)
- 1.15%
- Total Yield
- 1.15%
Company Profile
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through Generic Formulation Business segments. Geographically, the business activities are carried out across Indian and International markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 15,503
- Website
- https://www.torrentpharma.com
Comparables
Valuation
Metric
|
TORNTPHARM
|
533573
|
DIVISLAB
|
---|---|---|---|
Price/Earnings (Normalized) | 60.84 | 34.42 | 65.10 |
Price/Book Value | 13.12 | 4.32 | 7.21 |
Price/Sales | 8.53 | 3.24 | 12.37 |
Price/Cash Flow | 38.11 | 24.96 | 59.40 |
Price/Earnings
TORNTPHARM
533573
DIVISLAB
Financial Strength
Metric
|
TORNTPHARM
|
533573
|
DIVISLAB
|
---|---|---|---|
Quick Ratio | 0.55 | 0.72 | 5.54 |
Current Ratio | 1.08 | 1.73 | 8.79 |
Interest Coverage | 6.63 | 10.47 | 5,189.00 |
Quick Ratio
TORNTPHARM
533573
DIVISLAB
Profitability
Metric
|
TORNTPHARM
|
533573
|
DIVISLAB
|
---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
TORNTPHARM
533573
DIVISLAB
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pwqzkjgjd | Rwm | $77.5 Bil | |
MKKGY
| Merck KGaA ADR | Drzcvlglh | Ncnsnz | $76.9 Bil | |
HLN
| Haleon PLC ADR | Jjlxgxmp | Ymfzh | $38.4 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rdgsmgbm | Lwfnc | $15.9 Bil | |
VTRS
| Viatris Inc | Gfspgcsm | Sjhf | $14.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xyzfcbmx | Zrys | $12.3 Bil | |
CTLT
| Catalent Inc | Qxcmdvkmm | Lhckzb | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Mlygbbpj | Jdtwj | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Jjycbnrf | Sll | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jydgrmqfs | Nlpnw | $3.6 Bil |